These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7624833)

  • 1. In vivo labeling of sigma receptors in mouse brain with [3H]4-phenyl-1-(4-phenylbutyl)piperidine.
    Hashimoto K; Scheffel U; London ED
    Synapse; 1995 May; 20(1):85-90. PubMed ID: 7624833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological characterization of in vivo [3H]lfenprodil binding sites in the mouse brain.
    Benavides J; Peny B; Allen J; Scatton B
    J Pharmacol Exp Ther; 1992 Feb; 260(2):896-901. PubMed ID: 1310741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [3H]1-(cyclopropylmethyl)-4-(2-(4-fluorophenyl)-2-oxoethyl) piperidine HBr (DuP 734). A selective ligand for sigma receptors in mouse brain in vivo.
    Watanabe M; Rominger D; Hurt SD; De Souza EB; Tam SW
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1541-8. PubMed ID: 8371156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological and autoradiographic discrimination of sigma and phencyclidine receptor binding sites in brain with (+)-[3H]SKF 10,047, (+)-[3H]-3-[3-hydroxyphenyl]-N-(1-propyl)piperidine and [3H]-1-[1-(2-thienyl)cyclohexyl]piperidine.
    Largent BL; Gundlach AL; Snyder SH
    J Pharmacol Exp Ther; 1986 Aug; 238(2):739-48. PubMed ID: 3016248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase in extracellular acetylcholine level by sigma ligands in rat frontal cortex.
    Matsuno K; Matsunaga K; Senda T; Mita S
    J Pharmacol Exp Ther; 1993 May; 265(2):851-9. PubMed ID: 8496830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NPC 16377, a potent and selective sigma-ligand. I. Receptor binding, neurochemical and neuroendocrine profile.
    Karbon EW; Abreu ME; Erickson RH; Kaiser C; Natalie KJ; Clissold DB; Borosky S; Bailey M; Martin LA; Pontecorvo MJ
    J Pharmacol Exp Ther; 1993 May; 265(2):866-75. PubMed ID: 8388461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo binding of [3H]d-N-allylnormetazocine and [3H]haloperidol to sigma receptors in the mouse brain.
    Weissman AD; Broussolle EP; London ED
    J Chem Neuroanat; 1990; 3(5):347-54. PubMed ID: 2171560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of [18F]fluorinated sigma receptor ligands in the conscious monkey brain.
    Elsinga PH; Tsukada H; Harada N; Kakiuchi T; Kawamura K; Vaalburg W; Kimura Y; Kobayashi T; Ishiwata K
    Synapse; 2004 Apr; 52(1):29-37. PubMed ID: 14755630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of haloperidol and trifluperidol as subtype-selective N-methyl-D-aspartate (NMDA) receptor antagonists using [3H]TCP and [3H]ifenprodil binding in rat brain membranes.
    Coughenour LL; Cordon JJ
    J Pharmacol Exp Ther; 1997 Feb; 280(2):584-92. PubMed ID: 9023267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent sigma 1-receptor ligand 4-phenyl-1-(4-phenylbutyl) piperidine provides ischemic neuroprotection without altering dopamine accumulation in vivo in rats.
    Goyagi T; Bhardwaj A; Koehler RC; Traystman RJ; Hurn PD; Kirsch JR
    Anesth Analg; 2003 Feb; 96(2):532-8, table of contents. PubMed ID: 12538208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PPBP [4-phenyl-1-(4-phenylbutyl) piperidine], a potent sigma-receptor ligand, decreases brain injury after transient focal ischemia in cats.
    Takahashi H; Kirsch JR; Hashimoto K; London ED; Koehler RC; Traystman RJ
    Stroke; 1995 Sep; 26(9):1676-82. PubMed ID: 7544928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [3H]DuP 734 [1-(cyclopropylmethyl)-4-(2'-(4''-fluorophenyl)-2'- oxoethyl)-piperidine HBr]: a receptor binding profile of a high-affinity novel sigma receptor ligand in guinea pig brain.
    Culp SG; Rominger D; Tam SW; De Souza EB
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1175-87. PubMed ID: 1361573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [3H]RS-23597-190, a potent 5-hydroxytryptamine4 antagonist labels sigma-1 but not sigma-2 binding sites in guinea pig brain.
    Bonhaus DW; Loury DN; Jakeman LB; Hsu SA; To ZP; Leung E; Zeitung KD; Eglen RM; Wong EH
    J Pharmacol Exp Ther; 1994 Oct; 271(1):484-93. PubMed ID: 7965749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo labeling of 5-hydroxytryptamine uptake sites in mouse brain with [3H]-6-nitroquipazine.
    Hashimoto K; Goromaru T
    J Pharmacol Exp Ther; 1990 Oct; 255(1):146-53. PubMed ID: 2213550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [3H]DTG and [3H](+)-3-PPP label pharmacologically distinct sigma binding sites in guinea pig brain membranes.
    Karbon EW; Naper K; Pontecorvo MJ
    Eur J Pharmacol; 1991 Jan; 193(1):21-7. PubMed ID: 1675607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of sigma and phencyclidine receptor ligands with the norepinephrine uptake carrier in both rat brain and rat tail artery.
    Massamiri T; Duckles SP
    J Pharmacol Exp Ther; 1991 Feb; 256(2):519-24. PubMed ID: 1847198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a (+)-azidophenazocine-sensitive sigma receptor on splenic lymphocytes.
    Garza HH; Mayo S; Bowen WD; DeCosta BR; Carr DJ
    J Immunol; 1993 Nov; 151(9):4672-80. PubMed ID: 7691955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of ibogaine on the various sites of the NMDA receptor complex and sigma binding sites in rat brain.
    Itzhak Y; Ali SF
    Ann N Y Acad Sci; 1998 May; 844():245-51. PubMed ID: 9668682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeated haloperidol treatment decreases sigma(1) receptor binding but does not affect its mRNA levels in the guinea pig or rat brain.
    Inoue A; Sugita S; Shoji H; Ichimoto H; Hide I; Nakata Y
    Eur J Pharmacol; 2000 Aug; 401(3):307-16. PubMed ID: 10936488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rat liver and kidney contain high densities of sigma 1 and sigma 2 receptors: characterization by ligand binding and photoaffinity labeling.
    Hellewell SB; Bruce A; Feinstein G; Orringer J; Williams W; Bowen WD
    Eur J Pharmacol; 1994 Jun; 268(1):9-18. PubMed ID: 7925616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.